BioSpace News Archive

BioTech Medics, Inc. is pleased to announce that the Company continues to build the fundamental substructure that will enhance our ability to raise capital to position the organization in a competitive advantage with its calcium carbonate assets to enhance BMCS as a substantial publicly traded firm in this sector.

Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced today the first patient dosed in the VAN-2201 multi-center Phase 1 clinical trial evaluating treatment with KH631 for patients with wet Age-related Macular Degeneration (wet AMD).

Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2023 financial results and to provide a business update.

Medicovestor, Inc, a privately-held biopharmaceutical company focused on the development of novel antibody drug-conjugate therapies, proudly announces the successful completion of its oversubscribed Seed financing round.

Battelle, Andelyn Biosciences, Inc. , and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to manufacture suspension process gene therapy for the transformative treatment of Aspartylglucosaminuria (AGU).

The U.S. clinical oncology next generation sequencing market size was estimated at USD 166.9 million in 2022 and is expected to surpass around USD 687.04 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 15.2% during the forecast period 2023 to 2032.

The global artificial intelligence (AI) in biopharmaceutical market size was valued at USD 0.86 billion in 2022 and is projected to surpass around USD 14.07 billion by 2032, expanding at a remarkable CAGR of 32.3% from 2023 to 2032.

Foundation Medicine Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex®.

Qrons Inc. announced that Professor Shiri Navon-Venezia has agreed to join Qrons Scientific Advisory Board.

Vironova BioAnalytics, a leading provider of transmission electron microscopy services, is pleased to announce its acquisition led by QuatreLab with the participation of Accord Investment Partners and Venture Targeter AB.